Catechol Thioethers in Parkinson's Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00042692

Enrollment

Registered

2002-08-06

Start date

2001-03-31

Completion date

2002-03-31

Last updated

2006-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

catechol thioethers, Parkinson's disease, neurodegenerative disease

Brief summary

The goal of the clinical trial aim in this project is to test whether catechol thioethers can be used as biomarkers of dopaminergic neurodegeneration.

Interventions

None listed

Study design

Observational model

NATURAL_HISTORY

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

0 Years to No maximum

Healthy volunteers

Inclusion criteria

First diagnosis of Parkinson's disease.

Outcome results